Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial. WoS Publication

cited authors

  • Lam, Carolyn S P; Ramasundarahettige, Chinthanie; Branch, Kelley R H; Sattar, Naveed; Rosenstock, Julio; Pratley, Richard; Del Prato, Stefano; Lopes, Renato D; Niemoeller, Elisabeth; Khurmi, Nardev S; Baek, Seungjae; Gerstein, Hertzel C

authors

Publication Date

  • January 1, 2022

webpage

published in

start page

  • 565

end page

  • 574

volume

  • 145

issue

  • 8